Viatris VTRS
NASDAQ VTRS
$16.45 -0.16 (-0.93%)
As of: Sep 9, 2026 · 1:49 PM EDT

Viatris (VTRS) Other Operating Expenses (2019 - 2026)

Viatris (VTRS) posted Other Operating Expenses of -$73.2 million for Q2 2026, down 36.82% on a QoQ basis from -$53.5 million in Q1 2026, and down 253.78% year-over-year from $47.6 million in Q2 2025.

Analysis

Viatris (VTRS) Other Operating Expenses (2019 - 2026) Analysis & Trends

Viatris has reported Other Operating Expenses for 8 years, with the latest figure at -$73.2 million in Q2 2026.

  • On a quarterly basis, Other Operating Expenses fell 253.78% year-over-year to -$73.2 million in Q2 2026; TTM through Jun 2026 was -$179.3 million, a 715.0% decrease from a year earlier, with the FY2025 full-year figure at $68.5 million, up 119.52% from the prior year.
  • Other Operating Expenses was -$73.2 million for Q2 2026 at Viatris, down from -$53.5 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $73.5 million in Q1 2025, with the low at -$148.1 million in Q4 2023.
  • Average Other Operating Expenses over 5 years is -$29.2 million, with a median of -$8.5 million recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: Other Operating Expenses soared 569.23% in 2023, then plunged 12700.0% in 2024.
  • Over 5 years, Other Operating Expenses stood at $8.8 million in 2022, then plunged by 1782.95% to -$148.1 million in 2023, then grew by 24.65% to -$111.6 million in 2024, then soared by 102.78% to $3.1 million in 2025, then tumbled by 2461.29% to -$73.2 million in 2026.
  • The last three Other Operating Expenses figures came in at -$73.2 million (Q2 2026), -$53.5 million (Q1 2026), and $3.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.56 Bn 38.90 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.46 Bn 5.33 Bn 334.51 Mn
5 Bausch Health Companies 2.37 Bn 528.25 Mn 2.10 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn
9 Fennec Pharmaceuticals 411.43 Mn 370.18 Mn 17.15 Mn
10 RedHill Biopharma 181.39 Mn 181.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -73.20 Mn
Mar 31, 2026 -53.50 Mn
Dec 31, 2025 3.10 Mn
Sep 30, 2025 -55.70 Mn
Jun 30, 2025 47.60 Mn
Mar 31, 2025 73.50 Mn
Dec 31, 2024 -111.60 Mn
Sep 30, 2024 -31.50 Mn
Jun 30, 2024 -131.00 Mn
Mar 31, 2024 -76.80 Mn
Dec 31, 2023 -148.10 Mn
Sep 30, 2023 26.10 Mn
Jun 30, 2023 11.00 Mn
Mar 31, 2023 -600,000.00
Dec 31, 2022 8.80 Mn
Sep 30, 2022 3.90 Mn
Jun 30, 2022 -10.90 Mn
Mar 31, 2022 -6.20 Mn
Dec 31, 2021 -273.90 Mn
Sep 30, 2021 -9.40 Mn